218 related articles for article (PubMed ID: 21681091)
1. Cardiovascular disease and ovarian function.
Kallen AN; Pal L
Curr Opin Obstet Gynecol; 2011 Aug; 23(4):258-67. PubMed ID: 21681091
[TBL] [Abstract][Full Text] [Related]
2. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
Stevenson JC
Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
[TBL] [Abstract][Full Text] [Related]
3. Harnessing hormonal signaling for cardioprotection.
Ballard VL; Edelberg JM
Sci Aging Knowledge Environ; 2005 Dec; 2005(51):re6. PubMed ID: 16371658
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
6. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
7. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
9. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
Rossouw JE
Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
[TBL] [Abstract][Full Text] [Related]
10. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
11. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
Zárate A; Saucedo R; Basurto L; Martínez C
Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
[TBL] [Abstract][Full Text] [Related]
14. Androgens and menopause.
Shulman LP
Minerva Ginecol; 2009 Dec; 61(6):491-7. PubMed ID: 19942837
[TBL] [Abstract][Full Text] [Related]
15. Oestrogens and the heart.
Rosano GM; Panina G
Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
17. Aging, menopause, and free radicals.
Schwenke DC
Semin Reprod Endocrinol; 1998; 16(4):281-308. PubMed ID: 10101810
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
19. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
Ouyang P; Michos ED; Karas RH
J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
